Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives

As a typical pathological feature of pancreatic ductal adenocarcinoma, reprogramming of glucose metabolism synergistically drives the tumorigenesis and development process through molecular mechanisms such as regulating the expression of driver genes, modifying key functional proteins, triggering mi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Zhang, Wancheng Li, Jubao Niu, Zeyang Fan, Xin Li, Hui Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1586959/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473088617447424
author Yan Zhang
Wancheng Li
Jubao Niu
Zeyang Fan
Xin Li
Xin Li
Hui Zhang
Hui Zhang
author_facet Yan Zhang
Wancheng Li
Jubao Niu
Zeyang Fan
Xin Li
Xin Li
Hui Zhang
Hui Zhang
author_sort Yan Zhang
collection DOAJ
description As a typical pathological feature of pancreatic ductal adenocarcinoma, reprogramming of glucose metabolism synergistically drives the tumorigenesis and development process through molecular mechanisms such as regulating the expression of driver genes, modifying key functional proteins, triggering mitochondrial metabolism abnormality, and remodeling the tumor microenvironment. It is worth noting that this metabolic remodeling phenomenon is significantly associated with the formation of chemoresistance. Based on the latest research progress, this paper systematically describes the molecular basis of glucose metabolic reprogramming in pancreatic cancer, drug resistance characteristics and its targeted intervention strategies, and provides a theoretical framework for the research and development of innovative drugs.
format Article
id doaj-art-6b537221f13846c7af3ffe9ea13b0ecc
institution Kabale University
issn 1664-3224
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-6b537221f13846c7af3ffe9ea13b0ecc2025-08-20T03:24:16ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.15869591586959Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectivesYan Zhang0Wancheng Li1Jubao Niu2Zeyang Fan3Xin Li4Xin Li5Hui Zhang6Hui Zhang7The Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaDepartment of General Surgery, The Second Hospital of Lanzhou University, The Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaDepartment of General Surgery, The Second Hospital of Lanzhou University, The Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaAs a typical pathological feature of pancreatic ductal adenocarcinoma, reprogramming of glucose metabolism synergistically drives the tumorigenesis and development process through molecular mechanisms such as regulating the expression of driver genes, modifying key functional proteins, triggering mitochondrial metabolism abnormality, and remodeling the tumor microenvironment. It is worth noting that this metabolic remodeling phenomenon is significantly associated with the formation of chemoresistance. Based on the latest research progress, this paper systematically describes the molecular basis of glucose metabolic reprogramming in pancreatic cancer, drug resistance characteristics and its targeted intervention strategies, and provides a theoretical framework for the research and development of innovative drugs.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1586959/fullpancreatic cancerglucose metabolismtumor microenvironmenttreatment resistancetherapeutic strategy
spellingShingle Yan Zhang
Wancheng Li
Jubao Niu
Zeyang Fan
Xin Li
Xin Li
Hui Zhang
Hui Zhang
Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
Frontiers in Immunology
pancreatic cancer
glucose metabolism
tumor microenvironment
treatment resistance
therapeutic strategy
title Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
title_full Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
title_fullStr Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
title_full_unstemmed Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
title_short Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
title_sort reprogramming of glucose metabolism in pancreatic cancer mechanisms implications and therapeutic perspectives
topic pancreatic cancer
glucose metabolism
tumor microenvironment
treatment resistance
therapeutic strategy
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1586959/full
work_keys_str_mv AT yanzhang reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT wanchengli reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT jubaoniu reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT zeyangfan reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT xinli reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT xinli reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT huizhang reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives
AT huizhang reprogrammingofglucosemetabolisminpancreaticcancermechanismsimplicationsandtherapeuticperspectives